SCYX (STOCKS)
SCYNEXIS, Inc.
$1.010000
+0.010000 (+1.00%)
Prev close: $1.000000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- David Angulo Gonzalez
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $45.11M
- Employees
- 29
- P/E (TTM)
- -7.31
- P/B (TTM)
- 0.88
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$0.24 | $0.13 | +0.1129 | +87.35% |
|
Sep 2025 (Q3)
|
$-0.17 | $-0.20 | +0.0340 | +16.67% |
|
Jun 2025 (Q2)
|
$-0.14 | $-0.19 | +0.0538 | +27.76% |
|
Mar 2025 (Q1)
|
$-0.11 | $-0.18 | +0.0685 | +38.38% |
Financial Statements
| Revenues | $20.60M |
| Benefits Costs and Expenses | $29.21M |
| Costs And Expenses | $29.21M |
| Nonoperating Income/Loss | $7.47M |
| Operating Expenses | $36.68M |
| Selling, General, and Administrative Expenses | $14.40M |
| Research and Development | $22.28M |
| Operating Income/Loss | -$16.07M |
| Income/Loss From Continuing Operations After Tax | -$8.61M |
| Income/Loss From Continuing Operations Before Tax | -$8.61M |
| Income Tax Expense/Benefit | $0.00 |
| Income Tax Expense/Benefit, Current | $0.00 |
| Net Income/Loss | -$8.61M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$8.61M |
| Net Income/Loss Available To Common Stockholders, Basic | -$8.61M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.17 |
| Diluted Earnings Per Share | -$0.17 |
| Basic Average Shares | 49,933,381 |
| Diluted Average Shares | 49,933,381 |
| Assets | $59.03M |
| Current Assets | $40.37M |
| Cash | $56.30M |
| Noncurrent Assets | $18.65M |
| Liabilities | $9.65M |
| Current Liabilities | $5.73M |
| Accounts Payable | $2.23M |
| Other Current Liabilities | $3.51M |
| Noncurrent Liabilities | $3.92M |
| Equity | $49.38M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $49.38M |
| Liabilities And Equity | $59.03M |
| Net Cash Flow From Operating Activities | -$5.28M |
| Net Cash Flow From Operating Activities, Continuing | -$5.28M |
| Net Cash Flow From Investing Activities | $24.31M |
| Net Cash Flow From Investing Activities, Continuing | $24.31M |
| Net Cash Flow From Financing Activities | -$14.17M |
| Net Cash Flow From Financing Activities, Continuing | -$14.17M |
| Net Cash Flow | $4.85M |
| Net Cash Flow, Continuing | $4.85M |
| Comprehensive Income/Loss | -$8.61M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$8.61M |
| Other Comprehensive Income/Loss | $0.00 |